This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Lawrence Livermore National Security, LLC, The United States Government as Represented by the Department of Veterans Affairs, University of California. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2022
Title: The Innovations of Ralph William de Vere White
Introduction: Ralph William de Vere White, a distinguished inventor based in Sacramento, California, has made significant contributions to the field of oncology through his innovative methods focusing on chemotherapy treatments. With a total of two patents to his name, his work has paved the way for improved cancer therapies and patient outcomes.
Latest Patents: Ralph's latest patents illustrate his commitment to advancing cancer treatment methodologies. His patent titled "Methods for cytotoxic chemotherapy-based predictive assays" relates to innovative methods, systems, and kits designed to determine the therapeutic effectiveness or toxicity of cancer-treating compounds that bind to DNA. This invention specifically provides physicians with a diagnostic tool to predict a cancer patient's treatment outcome following the administration of a microdose of a therapeutic composition.
In addition, Ralph holds a patent for "Methods of improving cancer chemotherapy," which presents methods and compositions aimed at prolonging survival and reducing tumor growth in cancer subjects. This patent details a regimen that includes chemotherapeutic agents combined with an inhibitor of soluble epoxide hydrolase and a non-steroidal anti-inflammatory drug. These methodologies significantly decrease toxicity and adverse side effects associated with cancer treatments.
Career Highlights: Throughout his career, Ralph has held notable positions at esteemed institutions, including the University of California and The United States of America as represented by the Department of Veterans Affairs. His work at these organizations has allowed him to conduct impactful research and innovate in the field of cancer treatment.
Collaborations: Ralph has collaborated with respected colleagues such as Chong-Xian Pan and Paul Henderson. These partnerships have fostered an environment of shared ideas and expertise, further enhancing the innovations emerging from his research endeavors.
Conclusion: With his impressive patent portfolio and collaborative spirit, Ralph William de Vere White continues to play a crucial role in the evolution of cancer treatment methodologies. His dedication to improving patient outcomes demonstrates the importance of innovation in the field of medicine, particularly in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile